NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-06-08
DOI
10.1007/s00262-023-03471-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD1 in Metastatic Non-Small Cell Lung Cancer
- (2023) Kewen He et al. Cancer Immunology Research
- Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes
- (2021) Meenakshi Sharma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NLRP3 protects mice from radiation-induced colon and skin damage via attenuating cGAS-STING signaling
- (2021) Tiancong Wu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The AIM2 and NLRP3 inflammasomes trigger IL-1–mediated antitumor effects during radiation
- (2021) Chuanhui Han et al. Science Immunology
- Compliant Substrates Enhance Macrophage Cytokine Release and NLRP3 Inflammasome Formation During Their Pro-Inflammatory Response
- (2021) Joan-Carles Escolano et al. Frontiers in Cell and Developmental Biology
- Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects
- (2021) Yun Hu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Low-Dose Radiation Therapy Promotes Radiation Pneumonitis by Activating NLRP3 Inflammasome
- (2020) Xiaoyu Li et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
- (2020) Balamayoora Theivanthiran et al. JOURNAL OF CLINICAL INVESTIGATION
- SHP-2 and PD-L1 inhibition combined with radiotherapy enhances systemic antitumor effects in an anti-PD-1-resistant model of non-small-cell lung cancer
- (2020) Dawei Chen et al. Cancer Immunology Research
- The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury
- (2020) Shanshan Huang et al. Frontiers in Cell and Developmental Biology
- NLRP3 Inflammasome Activation in Lung Vascular Endothelial Cells Contributes to Intestinal Ischemia/Reperfusion-Induced Acute Lung Injury
- (2020) Homare Ito et al. JOURNAL OF IMMUNOLOGY
- NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
- (2020) Shaima'a Hamarsheh et al. Frontiers in Immunology
- Damage-associated molecular patterns in tumor radiotherapy
- (2020) Milad Ashrafizadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Bone morphogenetic protein 7 promotes resistance to immunotherapy
- (2020) Maria Angelica Cortez et al. Nature Communications
- Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
- (2020) Willemijn S M E Theelen et al. Lancet Respiratory Medicine
- Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer
- (2020) Mingyi Ju et al. BRIEFINGS IN BIOINFORMATICS
- Triple Therapy with MerTK and PD1 Inhibition plus Radiotherapy Promotes Abscopal Antitumor Immune Responses
- (2019) Mauricio S. Caetano et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
- (2019) James W. Welsh et al. Cancer Immunology Research
- Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
- (2018) Yang Liu et al. Journal of Hematology & Oncology
- Regulation of the NLRP3 inflammasome and macrophage pyroptosis by the p38 MAPK signaling pathway in a mouse model of acute lung injury
- (2018) Dandan Li et al. Molecular Medicine Reports
- Damage-Associated Molecular Patterns in Inflammatory Diseases
- (2018) Jong Seong Roh et al. Immune Network
- NLRP3 inflammasome activation mediates radiation-induced pyroptosis in bone marrow-derived macrophages
- (2017) Yan-gang Liu et al. Cell Death & Disease
- Inflammatory responses and inflammation-associated diseases in organs
- (2017) Linlin Chen et al. Oncotarget
- Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
- (2016) Xiaohong Wang et al. CANCER RESEARCH
- Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death
- (2016) Erica Salaro et al. Scientific Reports
- The inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice
- (2015) Sung-Hwa Sohn et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
- (2015) Jeremy Dupaul-Chicoine et al. IMMUNITY
- Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome
- (2015) Qing Wei et al. LABORATORY INVESTIGATION
- NLRP3 inflammasome and its inhibitors: a review
- (2015) Bo-Zong Shao et al. Frontiers in Pharmacology
- STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
- (2014) Liufu Deng et al. IMMUNITY
- Radiation Exposure Induces Inflammasome Pathway Activation in Immune Cells
- (2014) Veit M. Stoecklein et al. JOURNAL OF IMMUNOLOGY
- Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression
- (2013) Qing Wei et al. LABORATORY INVESTIGATION
- The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
- (2011) B. C. Burnette et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination
- (2011) W. Kratky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation-mediated promotion of invasion and metastasis
- (2010) Graziella Solinas et al. CANCER AND METASTASIS REVIEWS
- The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis
- (2010) Md. Hasan Zaki et al. IMMUNITY
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
- (2010) Irving C. Allen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation
- (2010) M. H. Zaki et al. JOURNAL OF IMMUNOLOGY
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
- (2009) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
- (2009) Luigi Franchi et al. NATURE IMMUNOLOGY
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started